The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...

The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. An ...

NerdWallet, Inc. does not offer advisory or brokerage services, nor does it recommend or advise investors to buy or sell particular stocks, securities or other investments. Get matched with a ...

Mr Mathieson said he was not aware of any links between Mr Wang and Star’s Hong Kong consortium partners, but reiterated that if the Macau investor wished to increase his stake he would face ...

The NSW Independent Casino Commission says a probity investigation into Macau investor Wang Xingchun will be required if his stake in the troubled Star Entertainment passes 10 per cent.